EcoDrugPlus

Adrenoceptor Beta 1

Ensembl ID : ENSRFEG00010009096
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSRFEG00010011504
Gene Symbol: ADRB2
1 Cross references
263 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSRFEG00010002348
Gene Symbol: ADRB3
1 Cross references
215 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSRFEG00010004736
Gene Symbol: AGER
1 Cross references
169 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSRFEG00010001303
Gene Symbol: ADH5
1 Cross references
401 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSRFEG00010011940
Gene Symbol: AKR1B1
1 Cross references
423 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSRFEG00010020025
Gene Symbol: GAA
1 Cross references
234 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSRFEG00010020404
Gene Symbol: AOC1
1 Cross references
230 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSRFEG00010010898
Gene Symbol: AOC3
1 Cross references
319 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSRFEG00010007377
Gene Symbol: APP
1 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSRFEG00010000079
Gene Symbol: AR
1 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSRFEG00010010462
Gene Symbol: ACE
1 Cross references
93 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).